Purchase Order W81K0222P0069
Award Date 7/22/22
Potential Completion Date 9/30/22
Potential Value $144K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
San Diego, CA 92122, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This firm fixed-price purchase order was awarded by the Defense Health Agency to Illumina, Inc., a manufacturer of genomic sequencing systems and reagents, for the procurement of Urinary Pathogen ID/AMR Enrichment Kits. The $61,848.39 contract has a period of performance through September 30, 2024 and will support the use of government-owned Illumina MiSeq sequencing instruments at Tripler Army Medical Center in Hawaii. The award was made on a sole source basis under the simplified acquisition...
- The Department of the Army Medical Command awarded a $247,627.76 firm fixed-price purchase order to Illumina, Inc., a for-profit manufacturing organization, for Illumina RNA Prep with Enrichment products and services. The contract does not have a set-aside designation. This award was made without full and open competition under the sole-source authority of FAR 13.106-1(b)(1)(i) based on Illumina's proprietary sequencing technology and status as the sole manufacturer. Illumina has a history of...
- This firm fixed-price purchase order, valued at $2,881,079.36, was awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genetic sequencing products and services. The contract supports genomic sequencing and analysis needs, with Illumina providing a range of sequencing systems, reagents, and bioinformatics products. This award does not have a set-aside designation. Illumina has previously received prime contract and subcontract awards from various federal...
- This firm fixed-price purchase order contract was awarded by the Medical Command (MEDCOM) of the U.S. Department of Defense to Illumina, Inc., a manufacturer of genomic sequencing systems and analytical tools. The $282,150.00 contract provides for the delivery of a MiSeq diagnostic sequencing system to support research and analysis at the U.S. Army's Fort Detrick facility in Maryland. Illumina has previously provided sequencing platforms and related services to federal agencies including the...
- This is a firm fixed price purchase order awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The contract, valued at $95,931.00, is for the delivery of a MiSeq System, a DNA sequencing instrument used for genomic research and diagnostics. While Illumina has previously received prime contract and sub-contract awards from other federal agencies such as the NIH, CDC, USDA, and VA to provide a range of its sequencing...
- This is a firm fixed price delivery order awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genetic sequencing systems and reagents. The $154,828.40 contract is for the purchase of reagents to support MEDCOM's genomic analysis and sequencing capabilities. Illumina has previously received other federal contracts and subcontracts from agencies like the National Institutes of Health, Centers for Disease Control, and Department of Veterans Affairs to provide...
- This is a firm fixed price delivery order contract valued at $242,110.64 awarded by the U.S. Army Medical Command (MEDCOM) to Illumina, Inc., a manufacturer of genetic sequencing instruments and reagents. The contract is for the provision of Illumina reagents to support the agency's sequencing and genomic analysis needs, without any set-aside designation. Illumina has a history of supporting federal agencies like the NIH, CDC, USDA, and VA with its sequencing systems and related products and...
- The Department of the Army Medical Command awarded a firm fixed price purchase order to Illumina, Inc., a for-profit manufacturer of sequencing and genomic analysis solutions, for the provision of a NextSeq 2000 Sequencing System. The total potential value of the award is $236,845.00. This requirement was solicited on a sole source basis due to Illumina's proprietary technology and the system's unique capabilities needed to support the U.S. Army Medical Research Institute of Infectious Diseases'...
- This is a firm fixed-price purchase order contract awarded by the U.S. Army Medical Command to Illumina, Inc., a manufacturer of sequencing and genomic analysis solutions. The contract is for a SEQUENCING SYSTEM with a ceiling value of $1,084,390.80 and a period of performance that runs through November 22, 2020. The contract does not have a set-aside designation. Illumina has provided sequencing systems, reagents, and services to support genomic research and analysis for various federal...
- This is a firm fixed price purchase order for $367,269.00 awarded by the Medical Command (MEDCOM) division of the U.S. Army to Illumina, Inc., a manufacturer of sequencing and genomic analysis instruments and reagents. The contract is for a NextSeq 500 sequencing system, with an ultimate completion date of November 18, 2020. Illumina has provided similar sequencing systems and related products and services to various federal agencies like the NIH, CDC, USDA, and VA in the past. This award is not...